Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Copaxone
Copaxone
Teva Pharmaceuticals: Valuation Is Too Depressed On Worries About Copaxone
Seeking Alpha
Mon, 11/5/12 - 11:30 am
Teva
Copaxone
MS
multiple sclerosis
Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around
Seeking Alpha
Wed, 10/31/12 - 11:16 am
Teva
Copaxone
Teva to Test MS Pill Laquinimod in Combination Therapy
Bloomberg
Thu, 10/11/12 - 10:21 am
Teva
MS
laquinimod
multiple sclerosis
Copaxone
Teva's 2nd-gen Copaxone makes the grade
Fierce Pharma
Wed, 10/10/12 - 11:59 am
Teva
Copaxone
MS
multiple sclerosis
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Seeking Alpha
Mon, 06/25/12 - 11:22 am
Teva Pharmaceuticals
patents
Mylan
Momenta
Natco
Acorda Therapeutics
Copaxone
MS
multiple sclerosis
Pharmaceuticals Swing; Teva, Pfizer, Bristol-Myers Moving Early
Barron's
Mon, 06/25/12 - 11:04 am
Teva Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Eliquis
Copaxone
Teva Jumps Most Since 2000 On Copaxone Ruling In U.S.
Bloomberg
Sun, 06/24/12 - 11:15 am
Teva Pharmaceuticals
Copaxone
generics
Patent Infringement
lawsuits
Mylan
Novartis
Momenta
Teva says MS drug met goals in clinical trial
PharmPro
Sat, 06/16/12 - 02:09 pm
Teva Pharmaceuticals
Copaxone
multiple sclerosis
Novartis limits use of Copaxone rival Gilenya
Globes, Israel
Sun, 04/22/12 - 01:31 pm
Novartis
Teva Pharmaceuticals
Gilenya
Copaxone
multiple sclerosis
Teva scrambling toward post-Copaxone future
Fierce Pharma
Wed, 02/15/12 - 01:33 pm
Teva Pharmaceuticals
Copaxone
Teva Rises to Eight-Month High on Novartis News
BusinessWeek
Sun, 01/22/12 - 12:28 pm
Teva Pharmaceuticals
Gilenya
Novartis
Copaxone
multiple sclerosis
Teva Heads to Biggest Drop Since 2006 on New Competition: Israel Overnight
Bloomberg
Fri, 12/30/11 - 09:14 am
Teva Pharmaceuticals
morning-after pill
Copaxone
Biogen-Idec's BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
Bradenton Herald, FL
Sun, 11/6/11 - 12:28 pm
Biogen
BG-12
multiple sclerosis
Teva Pharmaceuticals
Copaxone
CONFIRM
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Fierce Biotech
Wed, 10/26/11 - 09:11 am
Teva Pharmaceuticals
multiple sclerosis
MS
Copaxone
Biogen
BG-12
New Data On Teva’s Copaxone® And Laquinimod To Be Highlighted At ECTRIMS/ACTRIMS
The Street
Sat, 10/15/11 - 01:06 pm
Teva Pharmaceuticals
Copaxone
laquinimod
multiple sclerosis
Teva's Copaxone reduced brain volume loss in patients, according to study
Drugstore News
Wed, 10/12/11 - 10:51 am
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Antares Scores Key Patent Possibly Linked To TEVA's Copaxone
Seeking Alpha
Fri, 09/30/11 - 10:55 am
Antares
patents
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva defense of Copaxone starts today
Pharma Times, UK
Wed, 09/7/11 - 11:20 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Teva Gains to 4-Week High After U.S. Court Denies Motion
Bloomberg
Tue, 08/30/11 - 11:33 am
Teva Pharmaceuticals
patents
Copaxone
Mylan
MS
multiple sclerosis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »